搜索筛选:
搜索耗时1.4698秒,为你在为你在102,285,761篇论文里面共找到 49 篇相符的论文内容
类      型:
[会议论文] 作者:Pei Hu, 来源:第五届定量药理学与新药评价国际会议 年份:2015
Outline· Past-There was no guidance in those early years -Mainly conducted BE trials of generic drugs -Generic PK trials of imported drugs requested by SFDA ·...
[会议论文] 作者:Pei Hu, 来源:2007年定量药理学与新药临床评价国际学术会议 年份:2007
[会议论文] 作者:LiuTao,Pei Hu, 来源:The 3rd International Symposium of Quantitative Pharmacology 年份:2011
[会议论文] 作者:Rui Chen,Pei Hu, 来源:第十四届全国生化与分子药理学学术会议 年份:2015
[会议论文] 作者:Dongyang Liu,Pei Hu, 来源:第五届定量药理学与新药评价国际会议 年份:2015
[会议论文] 作者:Han Pei,Hu Yunquan, 来源:第二届中药现代化新剂型新技术国际学术会议 年份:2006
Traditional Chinese medicine has some special advantages for dealing with the unexpected events on epidemic disease.On the basis of analyzing the problems for traditional Chinese medicine at present,...
[会议论文] 作者:Rui Chen,Pei Hu, 来源:第十四届全国生化与分子药理学学术会议 年份:2015
Purpose:Cytochrome P450 2D6 (CYP2D6) is one of the most widely investigated polymor phic enzymes owing to its wide inter-individual and inter-ethnic variations.It is convenient to test genotypes clini...
[会议论文] 作者:Rui Chen,Pei Hu, 来源:第五届定量药理学与新药评价国际会议 年份:2015
Background and Aim: Hepatic enzyme CYP2D6 plays an important role in metabolizing many drugs and its genetic polymorphism results in significant individual therapeutic difference.Estimating the phenot...
[会议论文] 作者:Pei Hu,Xianluo Hu, 来源:第十四届全国太阳能光化学与光催化学术会议 年份:2014
During the past decades, photocatalysts have gained intensive attention with growing concerns of energy and environment problems.1 In particular, visible-light photocatalysts are more attractive in re...
[会议论文] 作者:Qian ZHAO,Ji JIANG,Pei HU, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Qian ZHAO,Ji JIANG,Pei HU, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Xin ZHENG,Qian ZHAO,Ji JIANG,Pei HU, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Warren T.K.Lee,Ji Jiang,X.J.Lai,Pei Hu,H.Y.Wang, 来源:International Conference on Osteoporosis and Bone Research 2 年份:2008
[会议论文] 作者:Xin ZHENG,Qian ZHAO,Ji JIANG,Pei HU, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Xinge Cui,Xin Zheng,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
[会议论文] 作者:Xin Zheng,Xia Chen,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
[会议论文] 作者:Xuemei Liu,Hongyun Wang,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
[会议论文] 作者:Yang Liu,Dongyang Liu,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Diabetes mellitus is one of the most common chronic disease in the world, CPRC 1 is a novel dipeptidylpeptidase-Ⅳ(DPP-4) inhibitor which was proposed to control hyperglycemia in patients with type 2 d...
[会议论文] 作者:Xuemei Liu,Hongyun Wang,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
CPRCX is a novel investigated proton pump inhibitor, which shows dramatic success in the management of acid-related disorders.Now this drug is being developed in Phase Ⅱ study in China.In this paper f...
[会议论文] 作者:Xin Zheng,Xia Chen,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
Background: Growth hormone deficiency (GHD) in paediatric and adult patients so currently necessitates long-term treatment and persistence with a daily s.c injection regimen.Taking the low compliance...
相关搜索: